Ascendis Pharma to Report First Quarter 2024 Financial Results and Provide Business Update on May 2, 2024 COPENHAGEN, Denmark, April 25, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will report first quarter 2024 financial results and provide a business update on Thursday, May 2, 2024, after the close of the U.S. financial markets. Ascendis Pharma will also host a conference call and live webcast on May 2, 2024, at 4:30 p.m. Eastern Time (ET) to discuss its first quarter 2024 financial results. Those who would like to participate may access the live we...
Tenaris anuncia los resultados del primer trimestre de 2024 La información financiera y operativa incluida en este comunicado de prensa está basada en estados contables intermedios consolidados condensados no auditados presentados en dólares estadounidenses (USD) y preparados de acuerdo con las Normas Internacionales de Información Financiera, según fueron emitidas por la Junta de Normas Internacionales de Contabilidad y adoptadas por la Unión Europea (NIIF). Asimismo, este comunicado de prensa incluye medidas alternativas del rendimiento que no son NIIF, es decir, EBITDA, Efectivo/deuda ne...
Tenaris Announces 2024 First Quarter Results The financial and operational information contained in this press release is based on unaudited consolidated condensed interim financial statements presented in U.S. dollars and prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standard Board and adopted by the European Union, or IFRS. Additionally, this press release includes non-IFRS alternative performance measures i.e., EBITDA, Net cash / debt, Free Cash Flow and Operating working capital days. See exhibit I for more details on t...
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024 Year-over-year revenue grows 7%, operating profit up 25%, non-GAAP operating profit up 23%Operating cash flows of $402 million Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended March 31, 2024. Third Quarter 2024 HighlightsAll comparisons are to the prior year period Revenue increased by 7% to $1.2 billion; up 7% on a constant currency ba...
TransUnion Announces First Quarter 2024 Results Exceeded first quarter 2024 financial guidance, delivering first $1 billion revenue quarter in company historyGrew revenue by 9 percent, driven by U.S. mortgage, International and Emerging VerticalsAchieved key milestones in our transformation program, including significant hiring in our Global Capability Centers and migration of key applications onto OneTru solutions enablement platformRaising 2024 financial guidance, we now expect to deliver 5 to 6.5 percent revenue growth for the year CHICAGO, April 25, 2024 (GLOBE NEWSWIRE) -- TransUn...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- ServiceNow (NYSE: NOW), the leading digital workflow company making the world work better for everyone, today announced financial results for its first quarter ended March 31, 2024, with subscription revenues of $2,523 million in Q1 2024, representing 25% year-over-year growth and 24.5% in constant currency. “ServiceNow is off to a fast start with an outstanding first quarter,” said ServiceNow Chairman and CEO Bill McDermott. “As leaders seek significant productivity improvements, ServiceNow has first mover advantage with years of investment in AI techn...
Ferrari enters into a partnership agreement with HP Maranello (Italy), April 24, 2024 – Ferrari N.V. (NYSE/EXM: RACE) announces that Ferrari S.p.A., wholly-owned Italian subsidiary of Ferrari N.V., today has signed a multiyear partnership agreement with HP Inc. (NYSE: HPQ), through which its brand will appear on racing properties of Scuderia Ferrari. Attachment
United Kingdom’s MHRA Approves YORVIPATH® (palopegteriparatide) in Great Britain for the Treatment of Adults with Chronic Hypoparathyroidism COPENHAGEN, Denmark, April 24, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the United Kingdom’s Medicines & Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for YORVIPATH® (palopegteriparatide; developed as TransCon™ PTH) in Great Britain as a parathyroid hormone (PTH) replacement therapy indicated for the treatment of adults with chronic hypoparathyroidism, and has also granted YOR...
Qorvo® Announces Date of 2024 Investor Day GREENSBORO, N.C., April 24, 2024 (GLOBE NEWSWIRE) -- Qorvo® (Nasdaq: QRVO), a leading global provider of connectivity and power solutions, today announced it will hold an Investor Day on Tuesday, June 11, 2024, in New York City from approximately 8:30 a.m. ET to approximately 11:30 a.m. ET. A live audio webcast and related presentation materials will be available to all interested parties on the Company’s investor relations website at the following URL: under “Events & Presentations.” To access the live webcast, please go to the Company’s IR we...
BlackLine Announces Date for First Quarter 2024 Earnings Release and Conference Call LOS ANGELES, April 23, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: BL) announced today that it will release financial results for the first quarter ended March 31, 2024 after market close on Tuesday, May 7, 2024 followed by a conference call hosted by management at 2:00 p.m. PT / 5:00 p.m. ET. A live webcast and replay will be accessible on BlackLine’s investor relations website at . To access the conference call by phone, please register , and dial-in details will be provided. To avoid delays, we encourage partic...
ICU Medical Announces Time of First Quarter 2024 Earnings Conference Call SAN CLEMENTE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2024 earnings release and conference call. The Company will release its first quarter 2024 results on Tuesday, May 7th, 2024 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Tuesday, May 7th, 2024. The cal...
STAMFORD, Conn.--(BUSINESS WIRE)-- Hexcel Corporation (NYSE: HXL) announced today that the Company’s Board of Directors has declared a regular quarterly cash dividend of $0.15 per share on the common stock of Hexcel, payable to stockholders of record as of May 3, 2024, with a payment date of May 10, 2024. About Hexcel is a global leader in advanced lightweight composites technology. We propel the future of flight, energy generation, transportation, and recreation through excellence in providing innovative high-performance material solutions that are lighter, stronger and tougher, helping ...
STAMFORD, Conn.--(BUSINESS WIRE)-- Hexcel Corporation (NYSE: HXL): Q1 2024 GAAP diluted EPS of $0.43 compared to Q1 2023 GAAP diluted EPS of $0.50. Q1 2024 adjusted diluted EPS of $0.44, compared to Q1 2023 adjusted diluted EPS of $0.50. Q1 2024 Sales were $472 million, an increase of 3.2% over Q1 2023 sales of $458 million (3.1% increase in constant currency). Returned $113 million in Q1 2024 to stockholders via share repurchases and dividends. Full year 2024 guidance is reaffirmed. See Table C for reconciliation of GAAP and non-GAAP operating income, net income, earni...
FERRARI TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 7 Maranello (Italy), April 22, 2024 - Ferrari N.V. (“Ferrari”) (NYSE/EXM: RACE) announced today that its financial results for the first quarter of 2024 will be released on Tuesday, May 7, 2024. A live audio webcast and conference call of the 2024 Q1 results will begin at 2:00 p.m. BST / 3:00 p.m. CEST / 9:00 a.m. EDT on Tuesday, May 7. Details for accessing this presentation will be available in the Investors section of Ferrari’s corporate website at prior to the event. Please note that registering in advance ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.